Headline
The latest stories from AHA Today.
Physicians registered with the Drug Enforcement Administration will no longer need to meet the X-waiver requirement to prescribe treatments such as buprenorphine for opioid use disorder, the Department of Health and Human Services announced.
Health and Human Services Secretary Alex Azar directed the department’s operating divisions and offices to review and revise their procedures related to civil enforcement actions and adjudications “to ensure that they promote fairness and transparency.”
The Centers for Medicare & Medicaid Services finalized additional provisions for the Medicare Advantage and Part D prescription drug programs beginning in 2022.
As urged by the AHA, the Centers for Medicare & Medicaid Services officially withdrew a proposed rule intended to increase oversight and transparency in Medicaid supplemental payment programs, including Disproportionate Share Hospital payments, and how states finance these programs.
The Centers for Medicare & Medicaid Services released a final rule that implements some of the standards governing health insurance issuers and the Health Insurance Marketplaces (or “exchanges”) for 2022.
The Centers for Medicare & Medicaid Services issued a final rule that seeks to streamline prior authorization processes implemented by health plans serving the Medicaid, Children’s Health Insurance Program and federal Health Insurance Marketplace.
President-elect Biden is planning to host a memorial to remember and honor the lives lost to COVID-19 on Tuesday, Jan. 19 — the night before he is inaugurated president.
As COVID-19 surges continue, lessons learned by health systems large and small reveal the importance of teamwork, communication, flexibility, preparation and supporting the physical and mental health of all staff.
The Department of Health and Human Services' Office for Civil Rights announced collaborative efforts with the state of North Carolina, the North Texas Mass Critical Care Guidelines Task Force, the Southwest Texas Regional Advisory Council, and the Indian Health Service in updating each entity’s…
President-elect Joe Biden named former Food and Drug Administration commissioner David Kessler, M.D., as Chief Science Officer of COVID Response, a role that will assume the responsibilities of the current head of Operation Warp Speed, the Trump administration effort focused on the development and…